[go: up one dir, main page]

NO20014383L - Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly) - Google Patents

Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)

Info

Publication number
NO20014383L
NO20014383L NO20014383A NO20014383A NO20014383L NO 20014383 L NO20014383 L NO 20014383L NO 20014383 A NO20014383 A NO 20014383A NO 20014383 A NO20014383 A NO 20014383A NO 20014383 L NO20014383 L NO 20014383L
Authority
NO
Norway
Prior art keywords
nmeval
dphe
cyclo
gly
asp
Prior art date
Application number
NO20014383A
Other languages
English (en)
Other versions
NO330030B1 (no
NO20014383D0 (no
Inventor
Alfred Jonczyk
Markus Arnold
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014383D0 publication Critical patent/NO20014383D0/no
Publication of NO20014383L publication Critical patent/NO20014383L/no
Publication of NO330030B1 publication Critical patent/NO330030B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20014383A 1999-03-11 2001-09-10 Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal). NO330030B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19910727 1999-03-11
PCT/EP2000/001751 WO2000053627A1 (de) 1999-03-11 2000-03-01 VERFAHREN ZUR HERSTELLUNG VON CYCLO-(Asp-DPhe-NMeVal-Arg-Gly)

Publications (3)

Publication Number Publication Date
NO20014383D0 NO20014383D0 (no) 2001-09-10
NO20014383L true NO20014383L (no) 2001-11-02
NO330030B1 NO330030B1 (no) 2011-02-07

Family

ID=7900511

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014383A NO330030B1 (no) 1999-03-11 2001-09-10 Fremgangsmate for fremstilling av syklo(Arg-Gly-Asp-DPhe-NMeVal), samt rettkjedede pentapeptider som mellomprodukter i syntesen av syklo(Arg-Gly-Asp-DPhe-NMeVal).

Country Status (28)

Country Link
US (1) US6822074B1 (no)
EP (1) EP1159296B1 (no)
JP (1) JP4762418B2 (no)
KR (1) KR100645002B1 (no)
CN (1) CN1200947C (no)
AR (1) AR022905A1 (no)
AT (1) ATE267839T1 (no)
AU (1) AU762540B2 (no)
BR (1) BR0008863A (no)
CA (1) CA2366694C (no)
CZ (1) CZ299879B6 (no)
DE (1) DE50006598D1 (no)
DK (1) DK1159296T3 (no)
ES (1) ES2221616T3 (no)
HK (1) HK1044780B (no)
HU (1) HUP0200369A3 (no)
ID (1) ID30126A (no)
MY (1) MY120083A (no)
NO (1) NO330030B1 (no)
PL (1) PL202996B1 (no)
PT (1) PT1159296E (no)
RU (1) RU2243974C2 (no)
SE (1) SE1159296T5 (no)
SK (1) SK285387B6 (no)
TW (1) TWI269798B (no)
UA (1) UA71608C2 (no)
WO (1) WO2000053627A1 (no)
ZA (1) ZA200108335B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0814519D0 (en) 2008-08-08 2008-09-17 Imp Innovations Ltd Process
WO2010130030A1 (en) * 2009-05-15 2010-11-18 National Research Counsil Of Canada Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
CA2762652C (en) * 2009-05-20 2018-10-02 Merck Patent Gmbh Novel solid materials of {[(2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
EP2509583B1 (en) 2009-12-10 2019-05-15 Merck Patent GmbH Pharmaceutical composition comprising oligopeptides, preferably cilengitide
CN103717205B (zh) 2011-06-09 2017-04-12 默克专利股份公司 用西仑吉肽在载体中的悬浮液治疗癌症和癌症转移
WO2019234108A1 (en) * 2018-06-05 2019-12-12 Dsm Ip Assets B.V. Methods for the synthesis of arginine-containing peptides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1038741B (de) * 1956-09-14 1958-09-11 Eberhard Brecklinghaus Aus Gummi oder einem anderen elastischen Werkstoff bestehender Kantenschoner fuer Treppenstufen aus Beton od. dgl.
US3630660A (en) * 1968-10-31 1971-12-28 Burlington Industries Inc Process for removal of moisture and/or solvents from textile materials
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
JPH06263798A (ja) * 1993-01-13 1994-09-20 Takeda Chem Ind Ltd βターン及びγターンを有する環状ペンタペプチド、その製造方法および用途
ATE179990T1 (de) * 1993-01-13 1999-05-15 Takeda Chemical Industries Ltd Cyclische pentapeptide mit beta-turn und gamma- turn
DE4310643A1 (de) 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
JPH10500969A (ja) * 1994-06-02 1998-01-27 ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング カルジオジラチンフラグメントの調製方法、高度に精製されたカルジオジラチンフラグメント及びそれらの調製のための中間生成物類
DE19534177A1 (de) 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19538741A1 (de) 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
DE19613933A1 (de) 1996-04-06 1997-10-09 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
EP0907661A4 (en) * 1996-05-31 2000-07-26 Scripps Research Inst METHODS AND COMPOSITIONS FOR INHIBITING ALPHA-V-BETA5 MEDIATED ANGIOGENESIS.
DE19728524A1 (de) * 1997-07-04 1999-01-07 Merck Patent Gmbh Cyclische Azapeptide

Also Published As

Publication number Publication date
EP1159296A1 (de) 2001-12-05
SE1159296T5 (no) 2004-09-07
JP4762418B2 (ja) 2011-08-31
DE50006598D1 (de) 2004-07-01
HK1044780B (zh) 2005-08-26
ZA200108335B (en) 2003-01-10
AU4103400A (en) 2000-09-28
NO330030B1 (no) 2011-02-07
AR022905A1 (es) 2002-09-04
HK1044780A1 (en) 2002-11-01
HUP0200369A2 (en) 2002-06-29
CN1200947C (zh) 2005-05-11
CZ299879B6 (cs) 2008-12-17
KR100645002B1 (ko) 2006-11-10
BR0008863A (pt) 2002-01-02
ES2221616T3 (es) 2005-01-01
SK12552001A3 (sk) 2002-05-09
ID30126A (id) 2001-11-08
CZ20013214A3 (cs) 2001-12-12
WO2000053627A1 (de) 2000-09-14
KR20010102503A (ko) 2001-11-15
MY120083A (en) 2005-08-30
RU2243974C2 (ru) 2005-01-10
ATE267839T1 (de) 2004-06-15
PL202996B1 (pl) 2009-08-31
NO20014383D0 (no) 2001-09-10
AU762540B2 (en) 2003-06-26
SE1159296T3 (no) 2004-08-24
HUP0200369A3 (en) 2002-09-30
CA2366694C (en) 2010-07-20
CN1343220A (zh) 2002-04-03
CA2366694A1 (en) 2000-09-14
UA71608C2 (en) 2004-12-15
PT1159296E (pt) 2004-10-29
TWI269798B (en) 2007-01-01
DK1159296T3 (da) 2004-09-27
US6822074B1 (en) 2004-11-23
EP1159296B1 (de) 2004-05-26
JP2002539137A (ja) 2002-11-19
SK285387B6 (sk) 2006-12-07

Similar Documents

Publication Publication Date Title
NO20015017D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20010318D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO20010319L (no) Fremgangsmate for fremstilling av Citalopram
NO20006039D0 (no) Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin
EE200100536A (et) Amiini-plaatina komplekside valmistamismeetod
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20005000D0 (no) FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO20020059L (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20014383D0 (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
NO20013407D0 (no) Fremgangsmåte for fremstilling av kinolinkarbaldehyd
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
NO20000805L (no) FremgangsmÕte for fremstilling av organiske azider
NO20022956L (no) Fremgangsmate for fremstilling av nitroguanidin
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
SI1080076T1 (sl) Izboljšan postopek za pripravo farmacevtsko pomembnih norbenzomorfanskih derivatov
EE200200053A (et) Isoretinoiini valmistamise protsess
NO20016271D0 (no) Fremgangsmåte for fremstilling av substituerte [1,4]diazepino[6,7,1-hi]indol-4-oner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees